Ryosuke Shimizu

1.2k total citations
50 papers, 915 citations indexed

About

Ryosuke Shimizu is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Ryosuke Shimizu has authored 50 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Ryosuke Shimizu's work include SARS-CoV-2 and COVID-19 Research (6 papers), Allergic Rhinitis and Sensitization (5 papers) and COVID-19 Clinical Research Studies (5 papers). Ryosuke Shimizu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Allergic Rhinitis and Sensitization (5 papers) and COVID-19 Clinical Research Studies (5 papers). Ryosuke Shimizu collaborates with scholars based in Japan, United States and New Zealand. Ryosuke Shimizu's co-authors include Hajime Mizukami, Toshiaki Makino, Masamitsu Moriwaki, Yukio Suzuki, Hiroshi Sakamoto, Kazuhiro MISUMI, Takuhiro Sonoyama, Takahiro Fukuhara, Ryuji Kubota and H. Tanaka and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

Ryosuke Shimizu

46 papers receiving 891 citations

Peers

Countries citing papers authored by Ryosuke Shimizu

Since Specialization

Citations

This map shows the geographic impact of Ryosuke Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Shimizu more than expected).

Fields of papers citing papers by Ryosuke Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Shimizu. The network helps show where Ryosuke Shimizu may publish in the future.

Co-authorship network of co-authors of Ryosuke Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Shimizu. A scholar is included among the top collaborators of Ryosuke Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Shimizu. Ryosuke Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor 2024 ·Infectious Diseases and Therapy ·Takayuki Katsube, (unknown), Ryosuke Shimizu, Ryuji Kubota	1
2	Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J) 2024 ·British Journal of Dermatology ·(unknown), Akio Tanaka, Hidetoshi Takahashi, Ryosuke Shimizu, Yoko Kataoka, Hitoe Torisu‐Itakura, Yoji Morisaki, Chie Yamamoto, Ken Igawa	2
3	Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis 2024 ·Acta Dermato Venereologica ·Akio Tanaka, Ken Igawa, Hidetoshi Takahashi, Ryosuke Shimizu, Yoko Kataoka, Hitoe Torisu‐Itakura, Yoji Morisaki, (unknown), Norito Katoh	7
4	Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19 2024 ·Infectious Diseases and Therapy ·D T Yamaguchi, Masaya Saito, (unknown), Ryosuke Shimizu, (unknown), (unknown), Ryuji Kubota, (unknown)	0
5	Evaluation of Drug‐Drug Interactions of Ensitrelvir, a SARS‐CoV‐2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies 2023 ·The Journal of Clinical Pharmacology ·Ryosuke Shimizu, Takanobu Matsuzaki, (unknown), Takuhiro Sonoyama, Takahiro Fukuhara, (unknown), (unknown), Ryuji Kubota	13
6	Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial 2023 ·Psychiatry and Clinical Neurosciences ·Masaki Kato, Kazuyuki Nakagome, (unknown), Takuhiro Sonoyama, Daiki Okutsu, (unknown), Ryosuke Shimizu, (unknown), Takeshi Inoue	17
7	530. Population Pharmacokinetic Analysis of Ensitrelvir, an Inhibitor of 3C-like (3CL) Protease of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for patients with SARS-Cov-2 Infection 2023 ·Open Forum Infectious Diseases ·Tôru Ishibashi, (unknown), Ryosuke Shimizu, Ryuji Kubota	1
8	A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations 2023 ·Clinical Drug Investigation ·Ryosuke Shimizu, Takuhiro Sonoyama, Takahiro Fukuhara, (unknown), (unknown), Ryuji Kubota	10
9	Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial 2023 ·Neuropsychopharmacology Reports ·Takuhiro Sonoyama, Ryosuke Shimizu, Ryuji Kubota, (unknown), Daiki Okutsu, (unknown), Keiko Takasu, Koichi Ogawa, (unknown)	6
10	Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures 2019 ·Clinical Pharmacokinetics ·Takayuki Katsube, Ryosuke Shimizu, Takahiro Fukuhara, Takeshi Kano, Toshihiro Wajima	9
11	Using Improved Serial Blood Sampling Method of Mice to Study Pharmacokinetics and Drug–Drug Interaction 2014 ·Journal of Pharmaceutical Sciences ·Ayahisa Watanabe, (unknown), (unknown), Ryosuke Shimizu, Yukari Tanaka, Nozomi Takai, (unknown), Yoshitaka Yamaguchi	16
12	Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice 2013 ·Journal of Natural Medicines ·Toshiaki Makino, (unknown), (unknown), Ryosuke Shimizu, H. Tanaka, Hajime Mizukami	73
13	Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis: A Randomized Double-Blind Placebo-Controlled Trial 2009 ·International Archives of Allergy and Immunology ·Mari Kawai, Tôru Hirano, Junsuke Arimitsu, Shinji Higa, Yusuke Kuwahara, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Atsushi Ogata, Mihoko Koyanagi, (unknown), Ryosuke Shimizu, Masamitsu Moriwaki, Yukio Suzuki, Satoshi Ogino, Ichiro Kawase, Toshio Tanaka	36
14	Enzymatic Production of Highly Soluble Myricitrin Glycosides Using β-Galactosidase 2006 ·Bioscience Biotechnology and Biochemistry ·Ryosuke Shimizu, (unknown), Masamitsu Moriwaki	26
15	Evaluation of Bone Maturation in Japanese Black Beef Cattle. 1996 ·Journal of Veterinary Medical Science ·(unknown), Shinichi Hamada, Hiroshi Sakamoto, (unknown), K. Yanagida, Chikara Kubota, Yoshio Watanabe, Ryosuke Shimizu	11
16	Epiphyseal Growth for 10 Months after Birth in Japanese Black Beef Cattle 1995 ·Journal of the Japan Veterinary Medical Association ·Ryosuke Shimizu, (unknown), (unknown), Hiroshi Sakamoto	1
17	Changes in Skeletal Muscle Composition in Response to Swimming Training for Young Horses. 1995 ·Journal of Veterinary Medical Science ·Kazuhiro MISUMI, Hiroshi Sakamoto, Ryosuke Shimizu	15
18	Changes in blood lactate and heart rate in thoroughbred horses during swimming and running according to their stage of training 1994 ·Veterinary Record ·Kazuhiro MISUMI, Hiroshi Sakamoto, Ryosuke Shimizu	21
19	Principal Component Analysis, Using the Measurements during Running and Swimming Test, in Thoroughbred Horses. 1994 ·Journal of Veterinary Medical Science ·Kazuhiro MISUMI, (unknown), Hiroshi Sakamoto, Ryosuke Shimizu	7
20	Partial Improvement of Olmsted Syndrome With Etretinate 1993 ·Pediatric Dermatology ·Masato Ueda, Koichi Nakagawa, Kazuhiro Hayashi, Ryosuke Shimizu, Masamitsu Ichihashi	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact